A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
NCT05248893
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
986
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Lines
Interventions
DRUG:
AGN-151586
Sponsor
AbbVie